FZMD (Fuse Medical) Cyclically Adjusted FCF per Share: $0.08 (As of Jun. 2023)


FZMD Fuse Medical Inc FZMD
12 GF Score
Price $0.03
View Full Analysis

What is Fuse Medical Cyclically Adjusted FCF per Share?

Fuse Medical FZMD +32.27% 12 Cyclically Adjusted FCF per Share is $0.08 as of Jun. 2023. GuruFocus rates FZMD with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Fuse Medical's adjusted free cash flow per share for the three months ended in Jun. 2023 was $-0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.08 for the trailing ten years ended in Jun. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-09), Fuse Medical's current stock price is $0.0291. Fuse Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 was $0.08. Fuse Medical's Cyclically Adjusted Price-to-FCF of today is 0.36.


Fuse Medical  (OTCPK:FZMD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Fuse Medical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=0.0291/0.08
=0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Fuse Medical Cyclically Adjusted FCF per Share Related Terms


Fuse Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Fuse Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuse Medical Cyclically Adjusted FCF per Share Chart

Fuse Medical Annual Data
Trend Aug13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.12 -0.06 0.00 0.04 0.07

Fuse Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 0.07 0.08 0.08

FZMD vs GTHP, SONX, PBIO: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Fuse Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuse Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fuse Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Fuse Medical's Cyclically Adjusted Price-to-FCF falls into.


FZMD
12GF Score
Fuse Medical Inc FZMD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuse Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fuse Medical's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.001/305.1090*305.1090
=-0.001

Current CPI (Jun. 2023) = 305.1090.

Fuse Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201308 0.835 233.877 1.089
201311 -0.155 233.069 -0.203
201403 -0.061 236.293 -0.079
201406 -0.093 238.343 -0.119
201409 -0.092 238.031 -0.118
201412 -0.076 234.812 -0.099
201503 -0.052 236.119 -0.067
201506 -0.016 238.638 -0.020
201509 0.009 237.945 0.012
201512 -0.006 236.525 -0.008
201603 0.011 238.132 0.014
201606 0.005 241.018 0.006
201609 -0.023 241.428 -0.029
201612 0.179 241.432 0.226
201703 0.076 243.801 0.095
201706 0.040 244.955 0.050
201709 0.024 246.819 0.030
201712 -0.003 246.524 -0.004
201803 0.011 249.554 0.013
201806 0.015 251.989 0.018
201809 0.018 252.439 0.022
201812 -0.006 251.233 -0.007
201903 0.001 254.202 0.001
201906 0.002 256.143 0.002
201909 -0.004 256.759 -0.005
201912 0.001 256.974 0.001
202003 -0.001 258.115 -0.001
202006 0.002 257.797 0.002
202009 0.006 260.280 0.007
202012 -0.003 260.474 -0.004
202103 0.001 264.877 0.001
202106 0.002 271.696 0.002
202109 0.001 274.310 0.001
202112 -0.028 278.802 -0.031
202203 0.007 287.504 0.007
202206 -0.003 296.311 -0.003
202209 0.009 296.808 0.009
202212 -0.011 296.797 -0.011
202303 0.005 301.836 0.005
202306 -0.001 305.109 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.08 mean?
Fuse Medical (FZMD) has a Cyclically Adjusted FCF per Share of $0.08 as of Jun. 2023. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Fuse Medical and its competitors.
Is Fuse Medical's Cyclically Adjusted FCF per Share too high?
Fuse Medical's current Cyclically Adjusted FCF per Share is $0.08. Overall, Fuse Medical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Fuse Medical's Cyclically Adjusted FCF per Share compare to GTHP and SONX?
Fuse Medical's Cyclically Adjusted FCF per Share of $0.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Fuse Medical and its competitors. Fuse Medical's current Cyclically Adjusted FCF per Share is $0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuse Medical stock overvalued right now?
Fuse Medical (FZMD) has a current Cyclically Adjusted FCF per Share of $0.08. The current Cyclically Adjusted FCF per Share is $0.08. Fuse Medical's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Fuse Medical (FZMD), the current Cyclically Adjusted FCF per Share is $0.08 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fuse Medical Business Description

Address 4343 Sigma Road, Suite 500, Farmers Branch, TX, USA, 75244
Fuse Medical Inc is a manufacturer, distributor, and wholesaler of medical device implants, offering portfolio of orthopedic implants and biologics including: internal fixation products, upper and lower extremity plating and total joint reconstruction implants, soft tissue fixation and augmentation for sports medicine procedures, spinal implants for trauma, degenerative disc disease and deformity indications, and osteo-biologics, regenerative and connective tissues, which include human allografts, substitute bone materials, tendons, and regenerative tissues. Its portfolio of Orthopedic Implants and Biologics provide products to assist surgeons with positive patient outcomes and cost-effective solutions for its customers including hospitals, medical facilities, and sub-distributors.
12GF Score

Get the complete analysis for FZMD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price